Summary

Secretary of Health and Human Resources; wholesale prescription drug importation program. Directs the Secretary of Health and Human Resources (the Secretary) to establish a wholesale prescription drug importation program that complies with the requirements of federal law and to report annually by October 1 to the Governor and the Chairmen of the House Committees on Appropriations and Health, Welfare and Institutions and the Senate Committees on Finance and Appropriations and Education and Health on the wholesale prescription drug importation program. The bill also requires the Secretary to (i) convene a workgroup composed of relevant stakeholders to develop a plan for implementation of the wholesale prescription drug importation program and report the plan to the Governor and the Chairmen of the House Committees on Appropriations and Health, Welfare and Institutions and the Senate Committees on Finance and Appropriations and Education and Health by December 1, 2022, and (ii) seek such federal approvals, waivers, exemptions, or agreements as may be necessary to enable all covered entities enrolled in or eligible for the federal 340B Drug Pricing Program to participate in the wholesale prescription drug importation program to the greatest extent possible without jeopardizing their eligibility for the 340B Drug Pricing Program by July 1, 2023.

Full Text

HOUSE BILL NO. 478
Offered January 12, 2022
Prefiled January 11, 2022
A BILL to amend the Code of Virginia by adding in Article 6 of Chapter 2 of Title 2.2 a section numbered 2.2-214.1:1, relating to Secretary of Health and Human Resources; wholesale prescription drug importation program.
----------
Patrons-- Subramanyam and Helmer
----------
Referred to Committee on Health, Welfare and Institutions
----------

Be it enacted by the General Assembly of Virginia:

1. That the Code of Virginia is amended by adding in Article 6 of Chapter 2 of Title 2.2 a section numbered 2.2-214.1:1 as follows:

2. That the Secretary of Health and Human Resources (the Secretary) shall convene a workgroup composed of relevant stakeholders to develop a plan for implementation of the wholesale prescription drug importation program established pursuant to this act, which shall include recommendations for any statutory, regulatory, budgetary, or policy changes necessary to implement the program. The Secretary shall report the plan to the Governor and the Chairmen of the House Committees on Appropriations and Health, Welfare and Institutions and the Senate Committees on Finance and Appropriations and Education and Health by December 1, 2022.

3. That the Secretary of Health and Human Resources shall (i) submit a formal request for certification of the Commonwealth's wholesale prescription drug importation program established pursuant to this act to the U.S. Department of Health and Human Services and (ii) seek such federal approvals, waivers, exemptions, or agreements as may be necessary to enable all covered entities enrolled in or eligible for the federal 340B Drug Pricing Program to participate in the wholesale prescription drug importation program established pursuant to this act to the greatest extent possible without jeopardizing such entities’ eligibility for the 340B Drug Pricing Program by July 1, 2023.

Bill Details

Status
failed committee
Outcome
failed
Introduced
2022-12-12
Patron
Sen. Suhas Subramanyam (D-Ashburn)
Party
D
District
32
Committee
n/a
Copatrons
0
Words
878

Status History

status: Left in Health, Welfare and Institutions
translation: failed committee
date: 11/22/2022
date_raw: 2022-11-22
lis_vote_id: H12V0005
vote_count:
status: Continued to 2023 in Health, Welfare and Institutions
translation:
date: 02/10/2022
date_raw: 2022-02-10
lis_vote_id: H12C0083
vote_count:
status: Subcommittee recommends continuing to 2023
translation:
date: 02/08/2022
date_raw: 2022-02-08
lis_vote_id: H1203C0019
vote_count:
status: Assigned HWI sub: Subcommittee #3
translation: in subcommittee
date: 01/25/2022
date_raw: 2022-01-25
lis_vote_id:
vote_count:
status: Impact statement from DPB (HB478)
translation:
date: 01/24/2022
date_raw: 2022-01-24
lis_vote_id:
vote_count:
status: Referred to Committee on Health, Welfare and Institutions
translation: in committee
date: 01/11/2022
date_raw: 2022-01-11
lis_vote_id:
vote_count:
status: Prefiled and ordered printed; offered 01/12/22 22102544D
translation: introduced
date: 01/11/2022
date_raw: 2022-01-11
lis_vote_id:
vote_count:

Related

[
    {
        "id": 63343,
        "number": "sb1425",
        "catch_line": "Health insurance; ensuring fairness in cost-sharing.",
        "date_introduced": "January 11, 2023",
        "name": "Commerce and Labor",
        "year": 2023,
        "status": "failed committee",
        "count": 1
    },
    {
        "id": 63369,
        "number": "hb2306",
        "catch_line": "Immunizations; authority of the Commissioner of Health, religious tenets or practices, exception.",
        "date_introduced": "January 11, 2023",
        "name": "Education and Health",
        "year": 2023,
        "status": "failed committee",
        "count": 1
    },
    {
        "id": 62135,
        "number": "sb972",
        "catch_line": "State Health Commissioner; powers in epidemic, religious tenets or practices.",
        "date_introduced": "January 06, 2023",
        "name": "Education and Health",
        "year": 2023,
        "status": "failed committee",
        "count": 1
    },
    {
        "id": 62075,
        "number": "hb1596",
        "catch_line": "Prescription Drug Affordability Board and Fund; established, report, drug cost affordability review.",
        "date_introduced": "January 06, 2023",
        "name": null,
        "year": 2023,
        "status": "failed committee",
        "count": 1
    },
    {
        "id": 63160,
        "number": "hb2276",
        "catch_line": "COVID; immunization of children.",
        "date_introduced": "January 11, 2023",
        "name": null,
        "year": 2023,
        "status": "failed committee",
        "count": 1
    }
]